PRIMECAP Odyssey Aggressive Growth (M:POAGX)

Add to Watchlists
Create an Alert
50.19 -0.57  -1.12% Jun 22 USD
View Full Chart
M:POAGX Total Returns Chart

M:POAGX Key Stats

M:POAGX Performance

  Total Return (Price) Cat. Total Return (NAV) % Rank in Cat. (NAV)
1M -0.04% 2.45% 97
3M -0.40% 3.59% 100
6M 12.79% 9.11% 16
YTD 13.22% 9.27% 15
1Y 28.25% 21.27% 10
3Y 16.87% 9.83% 2
5Y 20.75% 13.33% 1
10Y 17.39% 9.34% 1
As of June 22, 2018. Returns for periods of 1 year and above are annualized.

M:POAGX Asset Allocation

Type % Net % Long % Short
Cash 3.69% 3.69% 0.00%
Stock 96.03% 96.03% 0.00%
Bond 0.00% 0.00% 0.00%
Convertible 0.00% 0.00% 0.00%
Preferred 0.27% 0.27% 0.00%
Other 0.00% 0.00% 0.00%
As of March 31, 2018

M:POAGX Region Exposure

Americas 92.25%
North America 92.24%
Latin America 0.00%
Greater Europe 1.35%
United Kingdom 0.03%
Europe Developed 0.87%
Europe Emerging 0.00%
Africa/Middle East 0.45%
Greater Asia 6.41%
Japan 3.42%
Australasia 0.00%
Asia Developed 0.00%
Asia Emerging 2.99%
Market Classification
% Developed Markets 97.01%
% Emerging Markets 2.99%
As of March 31, 2018. Region breakdown data is calculated by using the long position holdings of the portfolio.

M:POAGX Stock Sector Exposure

Basic Materials 0.41%
Communication Services 1.10%
Consumer Cyclical 10.60%
Consumer Defensive 1.72%
Energy 0.28%
Financial Services 3.79%
Healthcare 38.66%
Industrials 13.34%
Real Estate 0.00%
Technology 30.10%
Utilities 0.00%
As of March 31, 2018

M:POAGX Stock Market Capitalization

Giant 13.14%
Large 34.26%
Medium 32.00%
Small 18.19%
Micro 2.42%
As of March 31, 2018

M:POAGX Stock Style Exposure

Large Cap Value 9.88%
Large Cap Blend 16.87%
Large Cap Growth 20.88%
Mid Cap Value 3.83%
Mid Cap Blend 4.43%
Mid Cap Growth 24.13%
Small Cap Value 1.51%
Small Cap Blend 4.13%
Small Cap Growth 14.33%
As of March 31, 2018
View More Holdings

M:POAGX Top 10 Holdings

Symbol Name % Weight Price % Chg
NKTR Nektar Therapeutics Inc 11.82% 52.85 -5.39%
ABMD Abiomed Inc 4.17% 427.29 -2.51%
ALKS Alkermes PLC 3.30% 44.13 +1.10%
SNE Sony Corp ADR 3.29% 50.37 +2.34%
MU Micron Technology Inc 3.20% 57.10 -3.94%
AAL American Airlines Group Inc 2.61% 41.35 -0.34%
BB.TO BlackBerry Ltd 2.46% 14.16 -9.29%
UAL United Continental Holdings Inc 2.29% 72.94 -1.99%
SFLY Shutterfly Inc A 2.05% 94.76 +0.65%
SGEN Seattle Genetics Inc 2.02% 66.85 +0.36%
As of March 31, 2018
Advertisement

M:POAGX One Page Reports

M:POAGX Basic Info

Style
Equity Style Mid Cap/Growth
Broad Asset Class US Equity
Broad Category Equity
Category Name Mid-Cap Growth
Prospectus Objective Aggressive Growth
Fund Owner Firm Name PRIMECAP Odyssey Funds
Benchmark Index
S&P 500 TR USD
100.0%

M:POAGX Manager Info

Name Tenure
Alfred Mordecai 13.50 yrs
James Marchetti 3.50 yrs
Joel Fried 13.50 yrs
M. Ansari 6.05 yrs
Theo Kolokotrones 13.50 yrs

M:POAGX Net Fund Flows

1M 50.09M
3M 141.17M
6M 240.92M
YTD 258.92M
1Y 209.05M
3Y -62.68M
5Y 1.864B
10Y 3.610B
As of May 31, 2018

M:POAGX Risk Info

Beta (5Y) 1.100
Historical Sharpe (10Y) 0.9281
Historical Sortino (All) 1.070
Daily Value at Risk (VaR) 1% (All) 3.64%
Monthly Value at Risk (VaR) 1% (All) 17.34%

M:POAGX Fundamentals

Dividend Yield TTM (6-22-18) 0.00%
SEC Yield --
Weighted Average PE Ratio 16.19
Weighted Average Price to Sales Ratio 2.263
Weighted Average Price to Book Ratio 3.893
Weighted Median ROE 7.78%
Weighted Median ROA -0.66%
Forecasted Dividend Yield 0.42%
Forecasted PE Ratio 17.17
Forecasted Price to Sales Ratio 2.106
Forecasted Price to Book Ratio 3.614
Number of Holdings 156
As of March 31, 2018

M:POAGX Growth Estimates

Forecasted 5 Yr Earnings Growth 14.58%
Forecasted Book Value Growth 5.69%
Forecasted Cash Flow Growth 7.69%
Forecasted Earnings Growth 5.33%
Forecasted Revenue Growth 3.77%
As of March 31, 2018

M:POAGX Comparables

Edit

M:POAGX Attributes

Purchase Details
Open to New Investors No
Open to Existing Investors Yes
Minimum Initial Investment 2000.00 USD
Minimum Subsequent Investment 100.00 USD
Fees
Actual 12B-1 Fee --
Actual Management Fee 0.55%
Administration Fee --
Performance Fee --
Switching Fee --
Transaction Fee --
Maximum Front Load --
Maximum Deferred Load --
Maximum Redemption Fee --
Key Dates
Inception Date 11/1/2004
Termination Date
Last Annual Report Date 10/31/2017
Last Prospectus Date
Attributes
Exchange Traded Share No
Exchange Traded Note No
Enhanced Index Fund No
Index Fund No
Inverse Fund No
Leveraged Fund No
Fund of Funds No
Currency Hedged Fund No
Synthetic Replication Fund No
Has Dividend Investment Plan No
Socially Responsible Fund No
General Availability
Available for Insurance Product No
Available for Retirement Plan No
Available for RRSP No

M:POAGX Excel Add-In Codes

  • Name: =YCI("M:POAGX","name")
  • Broad Asset Class: =YCI("M:POAGX", "broad_asset_class")
  • Broad Category: =YCI("M:POAGX", "broad_category_group")
  • Prospectus Objective: =YCI("M:POAGX", "prospectus_objective")

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.